Related Experiment Videos
Cost and cost-effectiveness studies in heart failure research
William S Weintraub1, Jason Cole, Joseph F Tooley
1Division of Cardiology, Emory University School of Medicine, Atlanta, Ga, USA. wweintr@emory.edu
Insights
Economic studies are crucial for making informed decisions about heart failure treatments. Reviewing cost-effectiveness in heart failure research helps optimize resource allocation for better patient outcomes.
Area of Science:
- Cardiology
- Health Economics
Background:
- Heart failure is a significant cause of death, disability, and resource utilization in the US.
- Prevalence is 4.6 million, with 550,000 new cases and 957,000 hospitalizations annually.
Purpose of the Study:
- To review methods for evaluating cost and outcome in heart failure research.
- To assess economic and cost-effectiveness studies within heart failure clinical trials.
Main Methods:
- Review of economic and cost-effectiveness studies.
- Analysis of therapeutic areas including digoxin, ACE inhibitors, beta blockers, disease management, and transplantation.
Main Results:
- Methods for cost-outcome evaluation and comparison are discussed.
- Economic studies in specific heart failure therapies are examined.
Conclusions:
- Economic studies aid rational decision-making amid resource constraints.
- Improved economic research in heart failure supports informed societal choices.
Background:
Heart failure is a major and increasing cause of death and disability and accounts for significant resource use. In the United States alone, the prevalence is 4.6 million, with an incidence rate of 550,000 new cases a year and approximately 957,000 hospitalizations a year.
Methods And Results:
Methods of evaluating cost and outcome and of comparing cost with outcome are reviewed. Economic and cost-effectiveness studies in heart failure research, especially those related to clinical trials, are reviewed in the therapeutic areas of digoxin, angiotension-converting enzyme inhibition, beta blockers, disease management, and transplantation.
Conclusion:
In an era in which economic constraints on medical resource use limit the ability to give all services to all patients, economic studies can help guide more rational decision making. Economic studies in heart failure can be expected to improve and so help society to make better, more informed choices.